Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 14/20 | 0.63 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.63 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.63 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.63 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20953915 | 0.93 | CACNA1C (0.68) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL11565239 | 0.89 | OPRM1 (0.68) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL9227658 | 0.88 | OPRM1 (0.62) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL11563405 | 0.88 | OPRM1 (0.68) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL15817257 | 0.87 | OPRM1 (0.66) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL18623777 | 0.83 | OPRM1 (0.76) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL8989441 | 0.82 | OPRM1 (0.82) | OPRM1OPRD1OPRK1CACNA1COPRL1 | |
| SCHEMBL2214001 | 0.81 | OPRM1 (0.69) | OPRM1OPRD1OPRK1CACNA1C | |
| SCHEMBL1952247 | 0.81 | CACNA1C (0.86) | OPRM1OPRD1OPRK1CACNA1C | |
| SCHEMBL11563541 | 0.80 | OPRM1 (0.82) | OPRM1OPRD1OPRK1CACNA1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| US-20220362160-A1 | ABUSE RESISTANT CAPSULE | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-11-17 | — | — | US | claimed |
| US-11464747-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2022-10-11 | — | — | US | claimed |
| EP-3446681-B1 | ABUSE RESISTANT CAPSULE | SCHERER TECHNOLOGIES LLC R P (US) | 2020-12-23 | — | — | EP | claimed |
| EP-2968129-B1 | ABUSE RESISTANT CAPSULE | SCHERER TECHNOLOGIES LLC R P (US) | 2018-09-05 | — | — | EP | claimed |
| US-20140271835-A1 | ABUSE RESISTANT CAPSULE | ARES CAPITAL CORPORATION, AS COLLATERAL AGENT | 2014-09-18 | — | — | US | claimed |
| EP-1515702-B1 | ABUSE-PROTECTED ADMINISTRATION FORM | GRUENENTHAL GMBH (DE) | 2008-10-15 | — | — | EP | claimed |
| US-20050191244-A1 | Abuse-resistant pharmaceutical dosage form | GRUENENTHAL GMBH (DE) | 2005-09-01 | — | — | US | claimed |
| US-20250345767-A1 | METHODS AND DEVICES FOR GENERATING CORE-SHELL DROPLETS AND PARTICLES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-11-13 | — | — | US | disclosed |
| EP-3824878-B1 | ABUSE RESISTANT CAPSULE | SCHERER TECHNOLOGIES LLC R P (US) | 2025-11-12 | — | — | EP | disclosed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | disclosed |
| US-20240108726-A1 | METHODS AND COMPOSITIONS FOR SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT | ACURA PHARMACEUTICALS, INC. (US) | 2024-04-04 | — | — | US | disclosed |
| US-11857629-B2 | Methods and compositions for self-regulated release of active pharmaceutical ingredient | ACURA PHARMACEUTICALS, INC. (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023239688-A1 | METHODS AND DEVICES FOR GENERATING CORE-SHELL DROPLETS AND PARTICLES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2023-12-14 | — | — | WO | disclosed |
| US-20080248113-A1 | ABUSE-PROOFED ORAL DOSAGE FORM | GRUNENTHAL GMBH (DE) | 2008-10-09 | — | — | US | disclosed |
| US-20070231268-A1 | Methods and compositions for deterring abuse of orally administered pharmaceutical products | ACURA PHARMACEUTICALS, INC. | 2007-10-04 | — | — | US | disclosed |
| US-20060177380-A1 | Methods and compositions for deterring abuse of orally administered pharmaceutical products | ACURA PHARMACEUTICALS, INC. | 2006-08-10 | — | — | US | disclosed |
| US-20060110327-A1 | Methods and compositions for deterring abuse of orally administered pharmaceutical products | ACURA PHARMACEUTICALS, INC. | 2006-05-25 | — | — | US | disclosed |
| US-20050236741-A1 | Process for the production of an abuse-proofed solid dosage form | ENDO PHARMACEUTICALS, INC. | 2005-10-27 | — | — | US | disclosed |
| US-20050191244-A1 | Abuse-resistant pharmaceutical dosage form | GRUENENTHAL GMBH (DE) | 2005-09-01 | — | — | US | disclosed |